Abzena Expands ADC Capabilities
Abzena has completed the facility remodeling for its new antibody-drug conjugate (ADC) GMP manufacturing suite at its Bristol, PA site.
The facility is being equipped with state-of-the-art Sartorius and GE equipment for single use scale-up, manufacture and purification processes. The environmentally controlled suite will enable Abzena to produce ADCs for preclinical and early phase clinical studies. The suite is a significant part of Abzena's integrated ADC capabilities for the design, development and manufacture of ADCs.
The facility and equipment verification and qualification for this ADC GMP manufacturing suite is currently underway, and scheduled for completion around the end of the second quarter of 2018.
Completion of the GMP ADC manufacturing suite construction marks a key point in Abzena's program to expand the group's integrated ADC chemistry solutions. This ADC manufacturing suite complements the existing GMP manufacturing capability for the scale-up and manufacture of highly potent payload-linker constructs, and the upgrading and expansion of Abzena's biologics process development and manufacturing capabilities in San Diego. The plans are on track for the initial relocation for Abzena's biologics manufacturing process and analytical development groups into the new San Diego facility during April 2018.
Abzena has existing client process development programs scheduled for the Bristol ADC manufacturing facility including an ADC utilizing the group's proprietary ThioBridge conjugation technology and another that has benefitted from an integrated program comprising cell line development, antibody production and development and manufacture of the ADC product including the linker-payload reagent.
"The completion of this facility is a significant step in realizing Abzena's vision of being a full service and technology provider for the design, development and manufacture of ADCs," said Sanjeevani Ghone, vice president and site head, Abzena, Bristol PA. "Our recent contracts are a testament to our client's confidence in our expertise and experience in this field."
2026-08-28
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Vietnam Drives ASEAN Towards a Modern Economy
-
Qatar LNG Hit by Attack: 17% Export Capacity Lost, $20 Billion Wiped Out
-
Hormuz Reopening Signal: 155 Tankers Still Waiting
-
USDA Puts Fresh Money Into Local Food Markets
-
Japan’s Three Major Chemical Companies Join Forces to Weather Challenges in the Plastics Industry
-
Biologicals Move from Trial Plots to Real Distribution
-
Spain’s Data-Protection Confusion Hits Pesticide Competitiveness
-
Spain’s Data-Protection Confusion Hits Pesticide Competitiveness
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
India Raises Cancer Drug Price Caps by 50%
Recommend Reading
-
New York Targets Additives and GRAS Disclosure
-
Shell Abandons Rotterdam Biofuels Complex as Costs Undermine Competitiveness
-
Bangladesh in Talks with Saudi Aramco Over LNG Supply MOU
-
Denmark to Boost Biomethane Output by 25% Within Two Years, Eyes Full Gas Transition
-
Evonik Starts Up 100,000 t/y Alkoxylates Plant in Singapore to Meet Surging Asian Demand
-
Insufficient downstream demand for DMF leads to a generally narrow and weak market performance
-
Insufficient Cost Support Leads to Wide-Ranging Decline in Acrylic Market
-
Raw Material Expectations Weak, ABS Market Shakes and Turns Down
-
This Week's Isopropanol Market Prices Decline (6.8-6.12) in China
-
Ethyl Acetate Prices Weakly Declining